Enrico Cortesi

Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).

L. Crinò, M. Clerici, M. Tonato, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised 'GISCAD' trial.

S. Barni, R. Labianca, G. Beretta, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO

G. Fontanini, E. Sensi, L. Boni, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary Tumor Sidedness and Benefit from FOLFOXIRI plus Bevacizumab as Initial Therapy for Metastatic Colorectal Cancer.

E. Sensi, L. Boni, G. Tonini, 2018 .

Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma

D. Amadori, R. Berardi, S. Cascinu, 2013, British Journal of Cancer.

Are post-docetaxel treatments effective in patients with castration-resistant prostate cancer and performance of 2? A meta-analysis of published trials

S. Cascinu, R. Iacovelli, M. Santoni, 2013, Prostate Cancer and Prostatic Disease.